CDNA CareDx Inc: Earnings growth forecast for next year

Public company logo of CareDx Corp (CDNA)

Tracking the history of consensus earnings estimates for the coming year on GURU.Markets, we note that the value has stabilized at -12.20. This trend is supported by a centralized laboratory structure that reduces costs and the implementation of autonomous robots for DNA analysis. The financial foundation of CareDx, Inc (CDNA) relies on high-margin genomic tests, AlloSure and AlloMap, which monitor the condition of transplanted organs.

CDNA: CareDx Health Earnings growth forecast for next year 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for CareDx, Inc. (CDNA)

- price and consensus price forecast:
General company analysis:CareDx
Finished products of CareDx

CareDx, Inc (CDNA) maintains a disciplined approach to transplant diagnostics and regulatory risks, ensuring high transparency for the data underpinning the calculated value of -12.20. This metric measures analyst consensus expectations for future profit dynamics, where narrowing volatility in the current assessment of the company's next-year EPS growth signals a stabilization of fundamental multiples and the determination of the business's fair market capitalization.

Competing companies

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|Expected earnings per share growth for next year MRVI|Expected net earnings per share growth next year Fulgent FLGT|Net earnings per share growth forecast for next year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Corp)|Consensus forecast of earnings per share growth for next year Exagen Inc. (XGN)|MDXH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year PRPH|Earnings growth forecast for next year AIMD|Projected earnings per share increase next year CODX|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year